EMEA-000914-PIP01-10-M04

Key facts

Invented name
Alprolix
Active substance
eftrenonacog alfa
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0296/2018
PIP number
EMEA-000914-PIP01-10-M04
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of hereditary factor-IX deficiency
Route(s) of administration
Intravenous use
Contact for public enquiries
Swedish Orphan Biovitrum AB (publ)

E-mail: medical.info@sobi.com
Tel. +46 8697 2000

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating